1. KLF6 degradation after apoptotic DNA damage.
- Author
-
Banck MS, Beaven SW, Narla G, Walsh MJ, Friedman SL, and Beutler AS
- Subjects
- Animals, Cell Line, Cisplatin pharmacology, Half-Life, Humans, Kruppel-Like Factor 6, Kruppel-Like Transcription Factors genetics, Mice, Neoplasms genetics, Neoplasms metabolism, Neoplasms pathology, Proteasome Endopeptidase Complex metabolism, Proteasome Inhibitors, Protein Binding, Proto-Oncogene Proteins genetics, TNF-Related Apoptosis-Inducing Ligand pharmacology, Time Factors, Tumor Necrosis Factor-alpha pharmacology, Ubiquitin metabolism, Apoptosis drug effects, DNA Damage, Kruppel-Like Transcription Factors metabolism, Proto-Oncogene Proteins metabolism
- Abstract
Krüppel-like factor 6 (KLF6) is a cancer gene (). Here, we demonstrate that KLF6 protein is rapidly degraded when apoptosis is induced via the intrinsic pathway by cisplatin, adriamycin, or UVB irradiation in multiple cell lines (HCT116, SW40, HepG2, PC3-M, Skov3, NIH-3T3, 293T, GM09706, and MEF, IMR-90). KLF6 degradation occurred in the presence or absence of p53, was associated with ubiquitination, mediated by the proteasome (half-life 16min, unstimulated), and independent of caspases and calpain. KLF6 was unchanged by apoptosis via the extrinsic/death-receptor pathway. Deregulation of KLF6 stability may alter its tumor suppressor function and/or the response of tumors to chemotherapeutics.
- Published
- 2006
- Full Text
- View/download PDF